Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"EC 2.7.10.1"
journalStr:"Cancer chemotherapy and pharmacology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
PubPharm (80)
1
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer : exposure-response relationship
enthalten in:
Cancer chemotherapy and pharmacology
| 2022
von
Nakagawa, K.
|
Garon, E.
|
Gao, L.
| +5
Wird geladen...
2
Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials
enthalten in:
Cancer chemotherapy and pharmacology
| 2021
von
Xiang, H.
|
Liu, L.
|
Gao, Y.
| +2
Wird geladen...
3
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study
enthalten in:
Cancer chemotherapy and pharmacology
| 2021
von
Wang, B.
|
Deng, R.
|
Hennig, S.
| +7
ErratumIn: Cancer Chemother Pharmacol. 2021 Sep 24;:. - PMID 34559287
Wird geladen...
4
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Yamashita-Kashima, Y.
|
Shu, S.
|
Osada, M.
| +4
ErratumIn: Cancer Chemother Pharmacol. 2020 Dec 18;:. - PMID 33337527
Wird geladen...
5
Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Xiang, H.
|
Liu, L.
|
Gao, Y.
| +5
Wird geladen...
6
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Mortimer, J.
|
Kruper, L.
|
Jung, J.
| +7
Wird geladen...
7
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
enthalten in:
Cancer chemotherapy and pharmacology
| 2019
von
Kirschbrown, W.
|
Wang, B.
|
Nijem, I.
| +8
Wird geladen...
8
Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer
enthalten in:
Cancer chemotherapy and pharmacology
| 2019
von
Lu, D.
|
Li, C.
|
Riggs, M.
| +10
Wird geladen...
9
Population pharmacokinetics of PF-05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2-positive metastatic breast cancer
enthalten in:
Cancer chemotherapy and pharmacology
| 2019
von
Chen, X.
|
Li, C.
|
Ewesuedo, R.
| +1
ErratumIn: Cancer Chemother Pharmacol. 2019 Sep;84(3):667. - PMID 31292683
Wird geladen...
10
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
enthalten in:
Cancer chemotherapy and pharmacology
| 2019
von
Kirschbrown, W.
|
Kågedal, M.
|
Wang, B.
| +15
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: EC 2.7.10.1
Filter aufheben
Zeitschrift: Cancer chemotherapy and pharmacology
Medienart
80
Aufsätze
73
E-Artikel
73
E-Ressourcen
7
Gedruckte Aufsätze
Zeitschriftentitel
Cancer chemotherapy and pharmacology
Thema
80
Antibodies, Monoclonal, Humanized
EC 2.7.10.1
80
Journal Article
43
Research Support, Non-U.S. Gov't
40
Antineoplastic Agents
39
Antibodies, Monoclonal
39
P188ANX8CK
39
Receptor, ErbB-2
39
Trastuzumab
28
ErbB Receptors
24
Clinical Trial, Phase I
24
ERBB2 protein, human
19
Multicenter Study
17
Cetuximab
17
PQX0D8J21J
14
EGFR protein, human
10
Taxoids
9
Clinical Trial, Phase II
9
K16AIQ8CTM
9
Randomized Controlled Trial
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2020-
56
2010-2019
18
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
80
Englisch
Haven't found what you're looking for?
Wird geladen...